Order Article Reprints

Apostolou P, Dellatola V, Papathanasiou A, Kalfakakou D, Fountzilas E, Tryfonopoulos D, Karageorgopoulou S, Yannoukakos D, Konstantopoulou I, Fostira F. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes. Cancers. 2024; 16(13):2368. https://doi.org/10.3390/cancers16132368

Apostolou, Paraskevi, Vasiliki Dellatola, Athanasios Papathanasiou, Despoina Kalfakakou, Elena Fountzilas, Dimitrios Tryfonopoulos, Sofia Karageorgopoulou, Drakoulis Yannoukakos, Irene Konstantopoulou, and Florentia Fostira. 2024. "Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes" Cancers 16, no. 13: 2368. https://doi.org/10.3390/cancers16132368

Apostolou, P., Dellatola, V., Papathanasiou, A., Kalfakakou, D., Fountzilas, E., Tryfonopoulos, D., Karageorgopoulou, S., Yannoukakos, D., Konstantopoulou, I., & Fostira, F. (2024). Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes. Cancers, 16(13), 2368. https://doi.org/10.3390/cancers16132368